[Renal tuberculosis treated with rifampicin, isoniazid and ofloxacin]

Enferm Infecc Microbiol Clin. 1992 Apr;10(4):216-9.
[Article in Spanish]

Abstract

We describe the results of eight patients with renal tuberculosis treated with rifampin, isoniazid and ofloxacin. Ofloxacin was given orally, 200 mg b.i.d. for 6 months. During the first three months, rifampin (600 mg/daily) and isoniazid (330 mg/daily) were added. All M. tuberculosis strains isolated were sensitive to ofloxacin (MIC 1 mg/l). Follow-up cultures turned to be negative rapidly (during the first month of therapy), and no untoward effects were recorded. All patients had a 12-months follow-up period, and all were clinically cured. The treatment used was well accepted by all patients.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Antitubercular Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Isoniazid / administration & dosage
  • Isoniazid / therapeutic use
  • Male
  • Middle Aged
  • Ofloxacin / administration & dosage
  • Ofloxacin / therapeutic use*
  • Rifampin / administration & dosage
  • Rifampin / therapeutic use
  • Tuberculosis, Renal / drug therapy*

Substances

  • Antitubercular Agents
  • Ofloxacin
  • Isoniazid
  • Rifampin